CHRNA1

CHRNA1

CHRNA1 (Cholinergic Receptor Nicotinic Alpha Subunit 1) encodes the alpha-1 subunit of the nicotinic [acetylcholine](/entities/acetylcholine) receptor (nAChR), a ligand-gated ion channel critical for neuromuscular junction (NMJ) formation and function. Mutations in CHRNA1 cause congenital myasthenic syndromes and are implicated in various neurological conditions.

Gene Overview

<div class="infobox infobox-gene">
| Property | Value |
|----------|-------|
| Gene Symbol | CHRNA1 |
| Full Name | Cholinergic Receptor Nicotinic Alpha Subunit 1 |
| Chromosomal Location | 2q31.1 |
| NCBI Gene ID | 1135 |
| OMIM | 100710 |
| Ensembl | ENSG00000138435 |
| UniProt | P30530 |
| Associated Diseases | Congenital myasthenic syndrome, myasthenia gravis, neuromuscular junction disorders |
</div>

Overview

CHRNA1 is a human gene whose product cHRNA1 is a key component of the muscle-type nAChR, a pentameric ligand-gated ion channel[@changeux2020]:. Variants in CHRNA1 have been implicated in Neuromuscular Disorders, Neurodegeneration. This page covers the gene's normal function, disease associations, expression patterns, and key research findings relevant to neurodegeneration.

Normal Function

CHRNA1 is a key component of the muscle-type nAChR, a pentameric ligand-gated ion channel[@changeux2020]:

CHRNA1

CHRNA1 (Cholinergic Receptor Nicotinic Alpha Subunit 1) encodes the alpha-1 subunit of the nicotinic [acetylcholine](/entities/acetylcholine) receptor (nAChR), a ligand-gated ion channel critical for neuromuscular junction (NMJ) formation and function. Mutations in CHRNA1 cause congenital myasthenic syndromes and are implicated in various neurological conditions.

Gene Overview

<div class="infobox infobox-gene">
| Property | Value |
|----------|-------|
| Gene Symbol | CHRNA1 |
| Full Name | Cholinergic Receptor Nicotinic Alpha Subunit 1 |
| Chromosomal Location | 2q31.1 |
| NCBI Gene ID | 1135 |
| OMIM | 100710 |
| Ensembl | ENSG00000138435 |
| UniProt | P30530 |
| Associated Diseases | Congenital myasthenic syndrome, myasthenia gravis, neuromuscular junction disorders |
</div>

Overview

CHRNA1 is a human gene whose product cHRNA1 is a key component of the muscle-type nAChR, a pentameric ligand-gated ion channel[@changeux2020]:. Variants in CHRNA1 have been implicated in Neuromuscular Disorders, Neurodegeneration. This page covers the gene's normal function, disease associations, expression patterns, and key research findings relevant to neurodegeneration.

Normal Function

CHRNA1 is a key component of the muscle-type nAChR, a pentameric ligand-gated ion channel[@changeux2020]:

Neuromuscular Transmission

• ACh Binding: The alpha-1 subunit contains the primary acetylcholine binding site
• Ion Channel: Forms the cation-permeable pore for Na⁺ and K⁺ influx
• Endplate Potential: Triggers muscle fiber depolarization at the NMJ

Receptor Structure

• Pentameric Assembly: Typically (α1)₂β1δ1ε1 in adult receptors
• Developmental Isoforms: Embryonic receptors contain γ instead of ε subunit
• Fast Synaptic Transmission: Millisecond-scale channel opening for rapid signaling

Signaling at NMJ

• Synaptic Differentiation: Essential for postsynaptic specialization
• Rapsyn Clustering: Partners with rapsyn for receptor anchoring
• Agrin-LRP4-MuSK: Downstream of the agrin signaling pathway

Disease Associations

Neuromuscular Disorders

• Congenital Myasthenic Syndrome (CMS): Over 100 mutations in CHRNA1 cause CMS[@chao2021]
• Myasthenia Gravis: Autoantibodies target nAChR including the alpha-1 subunit
• Slow Channel Syndrome: Gain-of-function mutations cause prolonged channel opening

Neurodegeneration

• ALS: Altered nAChR expression in motor [neurons](/entities/neurons)
• [Alzheimer's Disease](/diseases/alzheimers-disease): Neuronal nAChRs (α4β2, α7) are affected; muscle nAChR changes less studied
• Peripheral Neuropathy: Chemotherapy-induced neuropathy involves nAChR dysfunction

Expression Pattern

CHRNA1 is primarily expressed in:

• Skeletal Muscle: Highest expression in extraocular, limb, and trunk muscles
• Neuromuscular Junctions: Concentrated at the motor endplate
• Low/Restricted: Minimal expression in CNS neurons

Therapeutic Implications

Drug Targets

• Nicotinic Agonists: Nicotine and derivatives for cognitive enhancement
• Antagonists: Curare and derivatives for anesthesia
• Allosteric Modulators: Positive allosteric modulators in development

Research Directions

• Gene therapy for CMS
• Understanding nAChR dysfunction in neurodegenerative diseases

Cross-Links

• [CHRNB1](/genes/chrnb1) - Beta subunit
• [CHRND](/genes/chrnd) - Delta subunit
• [CHRNE](/genes/chrne) - Epsilon subunit
• [Myasthenia Gravis](/diseases/myasthenia-gravis) - Disease link
• [Neuromuscular Junction](/mechanisms/neuromuscular-junction) - Pathway

See Also

• [Myasthenia Gravis](/diseases/myasthenia-gravis)
• [Neuromuscular Junction](/mechanisms/neuromuscular-junction)

External Links

• [Ensembl: ENSG00000138435](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000138435)
• [NCBI Gene: CHRNA1](https://www.ncbi.nlm.nih.gov/gene/?term=CHRNA1)
• [GeneCards: CHRNA1](https://www.genecards.org/cgi-bin/carddisp.pl?gene=CHRNA1)
• [OMIM: CHRNA1](https://omim.org/search?search=CHRNA1)
• [Allen Brain Atlas: CHRNA1](https://human.brain-map.org/microarray/search/show?search_term=CHRNA1)

References